Archer Investment Corporation’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02K | Hold |
350
| – | – | ﹤0.01% | 1033 |
|
|
2025
Q1 | $343 | Hold |
350
| – | – | ﹤0.01% | 1063 |
|
|
2024
Q4 | $175 | Hold |
350
| – | – | ﹤0.01% | 1081 |
|
|
2024
Q3 | $1.31K | Hold |
350
| – | – | ﹤0.01% | 952 |
|
|
2024
Q2 | $1.96K | Hold |
350
| – | – | ﹤0.01% | 908 |
|
|
2024
Q1 | $1.83K | Hold |
350
| – | – | ﹤0.01% | 903 |
|
|
2023
Q4 | $1.83K | Hold |
350
| – | – | ﹤0.01% | 910 |
|
|
2023
Q3 | $5.52K | Buy |
350
+57
| +19% | +$899 | ﹤0.01% | 732 |
|
|
2023
Q2 | $5.7K | Hold |
293
| – | – | ﹤0.01% | 723 |
|
|
2023
Q1 | $8.31K | Buy |
+293
| New | +$8.31K | ﹤0.01% | 588 |
|